The preliminary results of accelerated hyperfractionated radiotherapy with involved-field omitted elective nodal irradiation (ENI) for inoperable advanced non-small cell lung cancer

Journal of JASTRO

Volumn 16, Issue 2, 2004, Pages 79-84

  Kimura, Tomoki ^a   Hirokawa, Yutaka ^a   Murakami, Yuji ^a   Kenjo, Masahiro ^a   Kaneyasu, Yuko ^a   Naito, Akira ^b   Ito, Shouko ^c   Ito, Katsuhide ^a  

^a HIROSHIMA UNIVERSITY   (Japan)

^b CHUGOKU ROSAI HOSPITAL   (Japan)

^c Department of Radiology   (Japan)

Author keywords

Accelerated hyperfractionated radiotherapy; Elective nodal irradiation; Involved field; Non small cell lung cancer

Indexed keywords

ANTINEOPLASTIC AGENT; CARBOPLATIN; CISPLATIN; NAVELBINE; PACLITAXEL;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CHEMOTHERAPY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER STAGING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; ESOPHAGITIS; FEMALE; FOLLOW UP; HUMAN; INOPERABLE CANCER; LUNG NON SMALL CELL CANCER; LUNG SQUAMOUS CELL CARCINOMA; LYMPH NODE METASTASIS; MALE; NEUTROPENIA; PNEUMONIA; RADIATION DOSE; SURVIVAL RATE;

EID: 3342928909     PISSN: 10409564     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (21)

1. Furuse K, Fukuoka M, Kawahara M, et al: Phase III study of concurrent versus sequential thoracic radiotherapy in combination with mitomycin, vindesine, and cisplatin in unresectable stage III non-small-cell lung cancer. J Clin Oncol 17: 2692-2699, 1999.
2. Komaki R, Seifeheld W, Curran W, et al: Sequential vs concurrent chemotherapy and radiation therapy for inoperable non-small-cell lung cancer: Analysis of failures in a phase III study (RTOG 9410). Int J Radiat Oncol Biol Phys 5: S5, 2001.
3. Perez CA, Pajak TF, Rubin P, et al: Long term observations of the patterns of failure in patients with unresectable non-oat cell carcinoma of the lung treated with definitive radiotherapy. Report by the Radiation therapy oncology Group. Cancer 59: 1874-1881, 1987.
4. Saunders M, Dische S, Barrett A, et al: Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: Mature data from a randomised multicentre trial. Radiother Oncol 50: 161-165, 1999.
5. Schaake-Koning C, van den Bogaert W, Dalesio O, et al: Effects of concomitant cisplatin and radiotherapy on inoperable non-small-cell lung cancer. N Engl J Med 326: 524-530, 1992.
6. Emami B and Graham MV: Lung. In: Perez C and Brady LW, ed. Principles and practice of radiation oncology. New York: Lippincott-Raven: 1181-1220, 1998.
7. Marks LB and Prosnitz LR: Assessing the impact of electiveregional radiotherapy on survival. Cancer Journal Sci Am 5: 75-76, 1999.
8. Pu AT, Harrison AS, Robertson JM, et al: The toxicity of elective nodal irradiation in the definitive treatment of non-small-cell carcinoma of the lung. Int J Radiat Oncol Biol Phys 39: 196, 1997.
9. Rosenzweig KE, Sim SE, Mychalczak B, et al: Elective nodal irradiation in the treatment of non-small-cell lung cancer with three-dimensional conformal radiation therapy. Int J Radiat Oncol Biol Phys 50: 681-685, 2001.
10. Senan S, Burgers S, Samson MJ, et al: Can elective nodal irradiation be omitted in stage III non-small-cell lung cancer? Analysis of recurrences in a phase II study of induction chemotherapy and involved-field radiotherapy. Int J Radiat Oncol Biol Phys 54: 999-1006, 2002.
11. National Cancer Institute: Common Terminology Criteria for Adverse Events v3.0 (CTCAC) 2003.
12. Liengswangwong V and Bonner JA: The potential importance of elective nodal irradiation in the treatment of n0n-small cell lung cancer. Seminars in Radiation Oncology 10: 308-314, 2000.
13. Webb WR, Gatsonis C, Zerhouni E, et al: CT and MR imaging in staging non-small cell bronchogenic carcinoma: Report of the Radiologic Diagnostic Oncology Group. Radiology 178: 705-713, 1991.
14. The Lung Cancer Study Group: Effects of postoperative mediastinal radiation on complete resected stage II and III epidermoid cancer of the lung. N Engl J Med 315: 1377-1381, 1986.
15. Medical Reserch Council Lung Cancer Working Party: The role of postoperative radiotherapy in non-small cell lung cancer: A multi-centre randomized trial in patients with pathologically staged T1-2, N1-2, M0 disease. Br J Cancer 74: 632-639, 1996.
16. Gupta NC, Tamim WJ, Graeber GG, et al: Mediastinal lymph node sampling following positron emission tomography with fluodeoxyglucose imaging in lung cancer staging. Chest 120: 521-527, 2001.
17. Vansteenkiste JF, Stroobants SG, De Leyn PR, et al: Lymph node staging in non-small cell lung cancer with FDG-PET scan: A prospective study on 690 lymph node stations from 68 patients. J Clin Oncol 16: 2142-2149, 1998.
18. Le Chevalier T, Arriagada R, Tarayre M, et al: Significant effect of adjuvant chemotherapy on survival in locally advanced non-small cell lung carcinoma. J Natl Cancer Inst 84: 58, 1992.
19. Choy H, et al: A phase II study of paclitaxel and carboplatin and hyperfractionated radiation therapy for locally advanced inoperable non-small cell lung cancer (a Vanderbilt cancer center affiliate network study). Int J Radiat Oncol Biol Phys 47: 931-937, 2000.
20. Cox JD, Pajak TF, Marcial VA, et al: Interruptions adversely affect local control and survival with hyperfractionated radiation therapy of carcinomas of the upper respiratory and digestive tracts. New evidence for accelerated proliferation from Radiation Therapy Oncology Group protocol 8313. Cancer 69: 2744-2748, 1992.